MedTrace Logo

Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome

NCT04292041 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-03-02

No results posted yet for this study

Summary

This is a prospective observational cohort study of patients with prostate cancer who have a metabolic syndrome. The study aims to evaluate the role of intermittent fasting (fasting mimicking diet) in these patients. The primary end point is metabolic health and the secondary endpoint is quality of life.

Conditions

Interventions

OTHER

Fasting mimicking diet

3 cycles of programmed nutrition using a fasting mimicking diet (Chemolieve (R)), each cycle consisting of 4 days. Pre and post nutritional cycles, clinical and metabolic assessments are taken, as per protocol. Allowing for a 3 month "washout" time, the 'post' assessment is planned approximately 6 months from the initial (pre) assessment.

Sponsors & Collaborators

  • Galway Clinic

    lead NETWORK

Principal Investigators

  • Frank Sullivan, MSc · Galway Clinic

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-06-15
Completion
2020-06-15

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04292041 on ClinicalTrials.gov